WITec Academy Established – Advanced Customer Training Program

WITec has established the WITec Academy as a new forum for advanced instrument and software operation training. It offers a variety of basic and expert level courses covering the entire range of WITec products and potential applications. Experienced and new users can both benefit from a graded course structure with seminars and extensive hands-on training [...]

‘gelcompany’ becomes new global brand of Fluorotechnics

2 February 2009 – Sydney, Australia: Fluorotechnics Limited (ASX:FLS), a global leader in the supply of fluorescence and other protein detection technologies, is changing its trading name and product branding to gelcompany. gelcompany is the new trading name for selling our products from San Francisco-based The Gel Company, German-based Elektrophorese-Technik GmbH (ETC) and Australian-based Fluorotechnics. [...]

Genedata and Roche Extend MS-based Proteomics Biomarker Discovery Collaboration

Genedata, a leading provider of in-silico solutions for pharmaceutical R&D and related life sciences, today announced a three-year license extension with Roche for the Refiner MS module of the Genedata Expressionist® biomarker discovery system. Refiner MS solves key requirements of large-scale proteomics and metabolomics facilities that need to efficiently process, analyze and store mass spectrometry [...]

Cambridge University Research Group Employs Fluidigm’s EP1 System for Cancer and Disease Association Studies

EP1 System Delivers Enhanced Work Flow and Great Data Quality Monday, February 2, 2009; South San Francisco, CA; Cambridge, UK – Fluidigm Corporation today announced that the Cancer Research UK Centre for Genetic Epidemiology, University of Cambridge, based at Strangeways Research Laboratory in the United Kingdom, has purchased the company’s EP1 System to conduct cancer [...]

MDS Announces Formation of Special Committee

TORONTO, Feb. 2 - MDS Inc. (TSX: MDS - News; NYSE: MDZ - News), a leading provider of products and services to the global life-sciences markets, today announced that it has constituted a committee of independent directors to support the Company's continuing process of reviewing alternatives to improve shareholder value. With the assistance of management [...]

Scienion appoints Guenter Bauer as CBO

Scienion AG today announced the appointment of Dr. Guenter Bauer as Chief Business Officer to Scienion’s management. The focus of his responsibilities will be sales and marketing. Bauer took up his new position on January 1, 2009. Dortmund, Berlin, Germany, January 20, 2009: Bauer is a senior business and technology development manager with scientific background [...]

BioGenes as new designated partner in EU funded dementia project

BioGenes GmbH, a specialist in sophisticated antibody development, has been chosen as a new partner of cNEUPRO. cNEUPRO is a EU funded research project to analyse neurodegenerative diseases and discover novel biomarkers, and so improve early and differential diagnosis of Alzheimer’s dementia. BioGenes will provide laboratory facilities and key personnel to develop specific monoclonal antibodies [...]

ProteOn Used to Rapidly Screen for Binding Affinities of Reagents

HERCULES, CA – January 29, 2009 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced today the University of Toronto selected the ProteOn™ XPR36 protein interaction array system to screen protein-specific affinity reagents, including antibodies and antibody fragments, as part of an [...]

Veeco Introduces Dimension Icon Atomic Force Microscope: Large-Sample AFM with Small-Sample Resolution

PLAINVIEW, N.Y.--Veeco Instruments Inc. (Nasdaq: VECO - News), the leading provider of atomic force microscopes (AFMs) to the nanoscience community, announced today the release of its Dimension® Icon™ AFM. Building upon the world’s most utilized large-sample AFM platform, the latest member of Veeco’s Dimension product line delivers the highest resolution, best ease-of-use, and fastest time-to-results [...]

Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test

Targets Diagnosis and Early Detection of Alzheimer’s and Parkinson’s Diseases OMAHA, Neb. and HOUSTON, Tex., Feb. 2, 2009 -- Transgenomic, Inc. (OTC BB: TBIO.OB) and Power3 Medical Products, Inc. (OTC BB: PWRM) today announced they have finalized a transaction, pursuant to their signed Letter of Intent announced December 2, 2008 (see “Transgenomic Signs Letter of [...]

Access IBO on Knowledge Center